BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 34210007)

  • 1. Cell-Penetrating Peptides and Transportan.
    Langel Ü
    Pharmaceutics; 2021 Jun; 13(7):. PubMed ID: 34210007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
    Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
    Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cargo delivery kinetics of cell-penetrating peptides.
    Hällbrink M; Florén A; Elmquist A; Pooga M; Bartfai T; Langel U
    Biochim Biophys Acta; 2001 Dec; 1515(2):101-9. PubMed ID: 11718666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein and siRNA delivery by transportan and transportan 10 into colorectal cancer cell lines.
    Wierzbicki PM; Kogut-Wierzbicka M; Ruczynski J; Siedlecka-Kroplewska K; Kaszubowska L; Rybarczyk A; Alenowicz M; Rekowski P; Kmiec Z
    Folia Histochem Cytobiol; 2014; 52(4):270-80. PubMed ID: 25511292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA).
    Bendifallah N; Rasmussen FW; Zachar V; Ebbesen P; Nielsen PE; Koppelhus U
    Bioconjug Chem; 2006; 17(3):750-8. PubMed ID: 16704214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of CPP-Based Methods for Delivery of miRNAs into the Skin and Airways: Lessons from Cell Culture and Mouse Models.
    Laanesoo A; Periyasamy K; Pooga M; Rebane A
    Methods Mol Biol; 2022; 2383():515-528. PubMed ID: 34766310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use.
    Carter E; Lau CY; Tosh D; Ward SG; Mrsny RJ
    Eur J Pharm Biopharm; 2013 Sep; 85(1):12-9. PubMed ID: 23958314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application.
    Xie J; Bi Y; Zhang H; Dong S; Teng L; Lee RJ; Yang Z
    Front Pharmacol; 2020; 11():697. PubMed ID: 32508641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-penetrating peptides: mechanisms and applications.
    El-Andaloussi S; Holm T; Langel U
    Curr Pharm Des; 2005; 11(28):3597-611. PubMed ID: 16305497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of splice correction by cell-penetrating peptide nucleic acids.
    El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
    J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pharmacokinetics of cell-penetrating peptides.
    Sarko D; Beijer B; Garcia Boy R; Nothelfer EM; Leotta K; Eisenhut M; Altmann A; Haberkorn U; Mier W
    Mol Pharm; 2010 Dec; 7(6):2224-31. PubMed ID: 20845937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.
    Lukanowska M; Howl J; Jones S
    Biotechnol J; 2013 Aug; 8(8):918-30. PubMed ID: 23843291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
    Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
    Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocation of cell penetrating peptides on Chlamydomonas reinhardtii.
    Suresh A; Kim YC
    Biotechnol Bioeng; 2013 Oct; 110(10):2795-801. PubMed ID: 23612985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taming Cell Penetrating Peptides: Never Too Old To Teach Old Dogs New Tricks.
    Zhang Q; Gao H; He Q
    Mol Pharm; 2015 Sep; 12(9):3105-18. PubMed ID: 26237247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NickFect type of cell-penetrating peptides present enhanced efficiency for microRNA-146a delivery into dendritic cells and during skin inflammation.
    Carreras-Badosa G; Maslovskaja J; Periyasamy K; Urgard E; Padari K; Vaher H; Tserel L; Gestin M; Kisand K; Arukuusk P; Lou C; Langel Ü; Wengel J; Pooga M; Rebane A
    Biomaterials; 2020 Dec; 262():120316. PubMed ID: 32896817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular delivery of siRNA by cell-penetrating peptides modified with cationic oligopeptides.
    Ishihara T; Goto M; Kodera K; Kanazawa H; Murakami Y; Mizushima Y; Higaki M
    Drug Deliv; 2009 Apr; 16(3):153-9. PubMed ID: 19514975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vectors for the nonviral delivery of nucleic acids.
    Hoyer J; Neundorf I
    Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides: Nanocarrier for macromolecule delivery in living cells.
    Chugh A; Eudes F; Shim YS
    IUBMB Life; 2010 Mar; 62(3):183-93. PubMed ID: 20101631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.